Anand Sharma seeks greater market access for Indian pharma products in Russia
Asks for regulatory simplification for Indian generic medicines supply to Russia
BS B2B Bureau B2B Connect | New Delhi
The Indian Minister asked for regulatory simplification for supply of Indian generic medicines to Russia. During the recently held 19th India Russia Working Group on Trade and Economic Cooperation (IRWGTEC) meeting in Moscow, the India had requested Russia to examine the issues troubling the Indian pharmaceutical companies. Sharma said, “As Indian pharma companies are keen to establish manufacturing bases in Russia, it is imperative that Russian government should address their concerns in an expeditious manner.”
ALSO READ: New draft of National Chemicals Policy should be ready in one month: Indrajit Pal, Secretary, DCP
More From This Section
Sharma along with Russian Ministers reviewed the identified projects. Under petrochemical industry, both sides expressed satisfaction over the progress made by plant construction unit for manufacturing butyl rubber with capacity of 1,00,000 tonnes per year at the production site of Reliance Industries in Jamnagar in Gujarat. The new complex will be the biggest in India and one of the biggest in the world regarding butyl rubber production.
ALSO READ: HPCL's Rs 37,230-crore refinery in Rajasthan gets Cabinet nod
In early 2010, SIBUR holding, a Russian petrochemical company and Reliance Industries signed a MoU regarding establishment of the joint venture for rubber production in India. Sharma and his counterpart expressed hope that the plant, the construction of which started in February 2013, will be operational by 2015 as per the schedule.
Also Read
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 21 2013 | 10:54 AM IST